Annual Current Assets
$36.06 M
-$31.23 M-46.41%
December 31, 2023
Summary
- As of February 7, 2025, ONCT annual total current assets is $36.06 million, with the most recent change of -$31.23 million (-46.41%) on December 31, 2023.
- During the last 3 years, ONCT annual current assets has fallen by -$81.94 million (-69.44%).
- ONCT annual current assets is now -76.32% below its all-time high of $152.26 million, reached on December 31, 2007.
Performance
ONCT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$15.45 M
-$7.81 M-33.58%
September 30, 2024
Summary
- As of February 7, 2025, ONCT quarterly total current assets is $15.45 million, with the most recent change of -$7.81 million (-33.58%) on September 30, 2024.
- Over the past year, ONCT quarterly current assets has dropped by -$13.06 million (-45.81%).
- ONCT quarterly current assets is now -89.86% below its all-time high of $152.26 million, reached on December 31, 2007.
Performance
ONCT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ONCT Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.4% | -45.8% |
| 3 y3 years | -69.4% | -73.3% |
| 5 y5 years | +15.5% | -73.3% |
ONCT Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.2% | at low | -83.4% | at low |
| 5 y | 5-year | -69.4% | +73.5% | -86.9% | at low |
| alltime | all time | -76.3% | +2238.5% | -89.9% | +24.0% |
Oncternal Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.45 M(-33.6%) |
| Jun 2024 | - | $23.26 M(-18.4%) |
| Mar 2024 | - | $28.50 M(-21.0%) |
| Dec 2023 | $670.00 K(-50.8%) | $36.06 M(-15.1%) |
| Sep 2023 | - | $42.49 M(-15.1%) |
| Jun 2023 | - | $50.08 M(-13.5%) |
| Mar 2023 | - | $57.92 M(-13.9%) |
| Dec 2022 | $1.36 M(+85.9%) | $67.29 M(-10.0%) |
| Sep 2022 | - | $74.79 M(-7.6%) |
| Jun 2022 | - | $80.98 M(-4.8%) |
| Mar 2022 | - | $85.07 M(-8.4%) |
| Dec 2021 | $732.00 K(-9.2%) | $92.85 M(-6.7%) |
| Sep 2021 | - | $99.52 M(-7.5%) |
| Jun 2021 | - | $107.60 M(-4.9%) |
| Mar 2021 | - | $113.08 M(-4.2%) |
| Dec 2020 | $806.00 K(-15.8%) | $118.00 M(+419.7%) |
| Sep 2020 | - | $22.71 M(+26.0%) |
| Jun 2020 | - | $18.02 M(+8.8%) |
| Mar 2020 | - | $16.56 M(-20.3%) |
| Dec 2019 | $957.00 K(+746.9%) | $20.79 M(-13.6%) |
| Sep 2019 | - | $24.05 M(-19.5%) |
| Jun 2019 | - | $29.87 M(+32.6%) |
| Mar 2019 | - | $22.53 M(-27.8%) |
| Dec 2018 | $113.00 K(-28.9%) | $31.21 M(-22.3%) |
| Sep 2018 | - | $40.14 M(-15.6%) |
| Jun 2018 | - | $47.58 M(+39.1%) |
| Mar 2018 | - | $34.21 M(-25.8%) |
| Dec 2017 | $159.00 K(-22.1%) | $46.08 M(-17.2%) |
| Sep 2017 | - | $55.68 M(+312.9%) |
| Jun 2017 | - | $13.49 M(-28.1%) |
| Mar 2017 | - | $18.75 M(-22.8%) |
| Dec 2016 | $204.00 K(+43.7%) | $24.30 M(+56.4%) |
| Sep 2016 | - | $15.53 M(-28.9%) |
| Jun 2016 | - | $21.84 M(-17.8%) |
| Mar 2016 | - | $26.56 M(-16.7%) |
| Dec 2015 | $142.00 K(-71.6%) | $31.89 M(-13.6%) |
| Sep 2015 | - | $36.92 M(-10.6%) |
| Jun 2015 | - | $41.29 M(-8.9%) |
| Mar 2015 | - | $45.34 M(-9.6%) |
| Dec 2014 | $500.00 K | $50.15 M(+302.5%) |
| Sep 2014 | - | $12.46 M(-32.5%) |
| Jun 2014 | - | $18.45 M(-36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $29.05 M(+91.5%) |
| Dec 2013 | $434.00 K(-54.7%) | $15.17 M(-30.4%) |
| Sep 2013 | - | $21.79 M(-33.3%) |
| Jun 2013 | - | $32.64 M(-25.1%) |
| Mar 2013 | - | $43.60 M(-23.3%) |
| Dec 2012 | $959.00 K(-47.0%) | $56.81 M(-20.4%) |
| Sep 2012 | - | $71.34 M(+22.7%) |
| Jun 2012 | - | $58.16 M(-12.6%) |
| Mar 2012 | - | $66.52 M(-13.4%) |
| Dec 2011 | $1.81 M(-53.5%) | $76.85 M(-10.0%) |
| Sep 2011 | - | $85.34 M(-8.3%) |
| Jun 2011 | - | $93.08 M(+79.4%) |
| Mar 2011 | - | $51.88 M(-14.1%) |
| Dec 2010 | $3.89 M(-44.8%) | $60.36 M(+124.8%) |
| Sep 2010 | - | $26.85 M(-23.7%) |
| Jun 2010 | - | $35.18 M(-23.8%) |
| Mar 2010 | - | $46.17 M(-8.9%) |
| Dec 2009 | $7.05 M(-12.9%) | $50.67 M(-12.0%) |
| Sep 2009 | - | $57.58 M(-20.1%) |
| Jun 2009 | - | $72.08 M(-15.2%) |
| Mar 2009 | - | $84.95 M(-15.1%) |
| Dec 2008 | $8.09 M(+8.3%) | $100.02 M(-7.1%) |
| Sep 2008 | - | $107.65 M(-10.7%) |
| Jun 2008 | - | $120.57 M(-13.4%) |
| Mar 2008 | - | $139.16 M(-8.6%) |
| Dec 2007 | $7.47 M(-1.2%) | $152.26 M(+62.4%) |
| Sep 2007 | - | $93.73 M(-10.9%) |
| Jun 2007 | - | $105.21 M(-8.1%) |
| Mar 2007 | - | $114.54 M(-5.9%) |
| Dec 2006 | $7.55 M(+11.0%) | $121.70 M(+64.2%) |
| Sep 2006 | - | $74.14 M(+29.1%) |
| Jun 2006 | - | $57.41 M(-15.5%) |
| Mar 2006 | - | $67.95 M(-10.6%) |
| Dec 2005 | $6.81 M(-1.8%) | $76.00 M(+87.8%) |
| Sep 2005 | - | $40.48 M(-18.9%) |
| Jun 2005 | - | $49.90 M(-14.7%) |
| Mar 2005 | - | $58.49 M(-11.6%) |
| Dec 2004 | $6.93 M(+203.1%) | $66.15 M(-14.4%) |
| Sep 2004 | - | $77.28 M(-7.3%) |
| Jun 2004 | - | $83.37 M(-5.8%) |
| Mar 2004 | - | $88.52 M(+489.2%) |
| Dec 2003 | $2.29 M(+114.8%) | $15.02 M |
| Dec 2002 | $1.06 M | - |
FAQ
- What is Oncternal Therapeutics annual total current assets?
- What is the all time high annual current assets for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual current assets year-on-year change?
- What is Oncternal Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly current assets year-on-year change?
What is Oncternal Therapeutics annual total current assets?
The current annual current assets of ONCT is $36.06 M
What is the all time high annual current assets for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total current assets is $152.26 M
What is Oncternal Therapeutics annual current assets year-on-year change?
Over the past year, ONCT annual total current assets has changed by -$31.23 M (-46.41%)
What is Oncternal Therapeutics quarterly total current assets?
The current quarterly current assets of ONCT is $15.45 M
What is the all time high quarterly current assets for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total current assets is $152.26 M
What is Oncternal Therapeutics quarterly current assets year-on-year change?
Over the past year, ONCT quarterly total current assets has changed by -$13.06 M (-45.81%)